2015-2019 Growth Strategiesin the Global Coagulation Testing Market for Instrument and Reagent Suppliers

coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrands Factor Fav/Ag, and others.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Sales and Market Share Analysis

- Sales and market shares of major
instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles of
major suppliers and emerging market entrants.

Market Segmentation Analysis

- Comprehensive market
segmentation analysis, including:

     - Hospitals
     - Commercial/Private Laboratories
     - Physician Offices
     - Ambulatory Care Centers

- Test volume forecasts  for over 40 major procedures,
by country and market segment.

Current and Emerging Products

- Review of established and emerging procedures.

- Comparison of automated and semi-automated
analyzers from Diagnostica Stago, Helena, IL,
Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies
and their potential market applications.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Worldwide Market Overview

- Estimates of facilities performing coagulation tests
by country.

- Test volume and sales projections by country.

Strategic Recommendations

- Product development and business expansion
opportunities with significant market appeal.

- “Ideal” product models with tentative
prices and operating characteristics.

- Alternative market penetration
strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.
                                                                     
Contains 650 pages and 150 tables

Related Reports

Competing in the Global Point-of-Care Diagnostic Testing Market
Competing in the Global Molecular Diagnostics Market
Competing in the Global Hematology and Flow Cytometry Market